Max Access Solutions is our innovative, patient-centered model for delivering cancer treatment to those in need. Through the program, launched in 2017, we connect people facing cancer in countries where treatment is not locally available to high-impact medicines, qualified medical professionals, and essential support services.
This work is made possible through partnerships with local physicians, ministries of health, other non-governmental organizations, patient organizations, and medicine manufacturers. Our partner physicians play a vital role in receiving the medication at the local level, enrolling patients into the program, and providing the individual care each patient needs.
Max Access Solutions is meant to bridge patients’ access to treatment in underserved areas, with a focus on low- and middle-income countries, until local access channels can be put in place.
- 40K+
patients provided access to medication and/or support services each year
- 80+
countries where medication access and/or support services are provided
- 17
medicines provided
Our Cancer Programs
For over 25 years, we’ve developed our cancer programs and expanded our partnerships to reach cancer patients in more than 80 low- and middle-income countries. We now offer a wide portfolio of life-extending medications for multiple disease areas and growing.
“As a teacher, I spent my life guiding others. During my illness, your support became a guiding light for me and my family. Thank you for turning the financial burden into an opportunity for recovery. I always taught my students that knowledge and care change lives and your support showed me that the same is true for healing.”
-Ram Nath, a retired teacher, father, and grandfather from Nepal living with renal cell carcinoma
Latest Developments
The Max Foundation Renews Partnership to Expand Access to Chronic Lymphocytic Leukemia Treatment
We have extended our partnership with BeOne Medicines and BeOne Care Foundation to provide access to treatment for chronic lymphocytic leukemia (CLL) in low- and middle-income countries, with the program projected to support approximately 1,000 patients cumulatively by the end of 2028. Read the full press release.
CancerWorld Special Issue
We’re excited to announce our collaboration with CancerWorld magazine! This special issue is about the 25th anniversary of an oral medication for chronic myeloid leukemia that transformed treatment, diagnostics, access, and patient advocacy. It features articles from the global community, including clinicians, researchers, patients, and advocates. Learn more about how a woman living with CML….
Partner physician article published in Clinical Surgical Oncology
An article by one of our partner physicians, Dr. Freddy Gnangnon in Benin, was recently published in Clinical Surgical Oncology. It’s about the management of locally advanced gastrointestinal stromal tumors and how providing access to treatment free of charge improves survival outcomes. Read More
Overcoming Barriers to Patient Access
Improving health outcomes for people living with cancer is about more than medication. We provide patient access solutions through psychosocial support, transportation assistance, adherence monitoring, and more to ensure patient needs are handled individually and holistically.
Learn More
2025 M&E Report
Download Report